Actinium Pharmaceuticals (ATNM) Competitors $1.56 -0.05 (-3.11%) Closing price 04:00 PM EasternExtended Trading$1.55 -0.01 (-0.64%) As of 05:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ATNM vs. MDWD, SLS, DERM, TARA, FTLF, SXTC, AVTX, IPHA, MCRB, and FBRXShould you be buying Actinium Pharmaceuticals stock or one of its competitors? The main competitors of Actinium Pharmaceuticals include MediWound (MDWD), SELLAS Life Sciences Group (SLS), Journey Medical (DERM), Protara Therapeutics (TARA), FitLife Brands (FTLF), China SXT Pharmaceuticals (SXTC), Avalo Therapeutics (AVTX), Innate Pharma (IPHA), Seres Therapeutics (MCRB), and Forte Biosciences (FBRX). These companies are all part of the "pharmaceutical products" industry. Actinium Pharmaceuticals vs. Its Competitors MediWound SELLAS Life Sciences Group Journey Medical Protara Therapeutics FitLife Brands China SXT Pharmaceuticals Avalo Therapeutics Innate Pharma Seres Therapeutics Forte Biosciences MediWound (NASDAQ:MDWD) and Actinium Pharmaceuticals (NYSE:ATNM) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, analyst recommendations, dividends, media sentiment, institutional ownership and profitability. Does the media prefer MDWD or ATNM? In the previous week, MediWound had 1 more articles in the media than Actinium Pharmaceuticals. MarketBeat recorded 5 mentions for MediWound and 4 mentions for Actinium Pharmaceuticals. MediWound's average media sentiment score of 0.70 beat Actinium Pharmaceuticals' score of -0.33 indicating that MediWound is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MediWound 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Actinium Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Is MDWD or ATNM more profitable? Actinium Pharmaceuticals has a net margin of 0.00% compared to MediWound's net margin of -142.18%. MediWound's return on equity of -96.71% beat Actinium Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets MediWound-142.18% -96.71% -39.73% Actinium Pharmaceuticals N/A -100.85%-47.89% Do insiders and institutionals have more ownership in MDWD or ATNM? 46.8% of MediWound shares are held by institutional investors. Comparatively, 27.5% of Actinium Pharmaceuticals shares are held by institutional investors. 9.2% of MediWound shares are held by insiders. Comparatively, 6.0% of Actinium Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Do analysts rate MDWD or ATNM? MediWound presently has a consensus price target of $32.25, suggesting a potential upside of 74.61%. Actinium Pharmaceuticals has a consensus price target of $4.50, suggesting a potential upside of 188.46%. Given Actinium Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe Actinium Pharmaceuticals is more favorable than MediWound.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MediWound 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50Actinium Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has stronger earnings and valuation, MDWD or ATNM? MediWound has higher revenue and earnings than Actinium Pharmaceuticals. MediWound is trading at a lower price-to-earnings ratio than Actinium Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMediWound$20.22M10.13-$30.22M-$2.64-7.00Actinium PharmaceuticalsN/AN/A-$48.82M-$1.31-1.19 Which has more risk and volatility, MDWD or ATNM? MediWound has a beta of 0.27, indicating that its stock price is 73% less volatile than the S&P 500. Comparatively, Actinium Pharmaceuticals has a beta of -0.25, indicating that its stock price is 125% less volatile than the S&P 500. SummaryMediWound beats Actinium Pharmaceuticals on 10 of the 15 factors compared between the two stocks. Get Actinium Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ATNM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ATNM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ATNM vs. The Competition Export to ExcelMetricActinium PharmaceuticalsPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$48.67M$1.03B$6.02B$21.83BDividend YieldN/A4.84%5.73%3.67%P/E Ratio-1.121.2885.1229.93Price / SalesN/A30.15589.7091.78Price / CashN/A17.6425.7717.79Price / Book1.197.7012.674.69Net Income-$48.82M-$7.59M$3.32B$1.01B7 Day Performance-1.27%10.61%0.49%0.13%1 Month Performance-4.29%22.16%9.41%1.50%1 Year Performance-12.36%-10.96%79.11%14.25% Actinium Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ATNMActinium Pharmaceuticals2.1641 of 5 stars$1.56-3.1%$4.50+188.5%-10.6%$48.67MN/A-1.1230News CoverageMDWDMediWound1.4672 of 5 stars$17.43+1.4%$32.25+85.0%+8.4%$194.94M$20.22M-6.6680Positive NewsSLSSELLAS Life Sciences Group2.1271 of 5 stars$1.84-2.6%$7.00+280.4%+61.3%$193.12M$1M-5.7310News CoveragePositive NewsOptions VolumeDERMJourney Medical2.037 of 5 stars$7.11-3.0%$12.17+71.1%+20.1%$193.06M$56.40M-19.3190News CoverageTARAProtara Therapeutics2.1631 of 5 stars$4.94+1.3%$19.60+297.2%+217.9%$190.79MN/A-3.0530FTLFFitLife Brands3.9362 of 5 stars$20.02-0.6%$23.00+14.9%+26.0%$188.10M$63.05M23.8520SXTCChina SXT Pharmaceuticals0.3841 of 5 stars$1.61-2.1%N/A-68.2%$186.23M$1.74M0.0090Gap DownAVTXAvalo Therapeutics3.3585 of 5 stars$14.15+1.1%$31.67+123.8%+43.3%$186.14M$440K0.0040Positive NewsAnalyst ForecastIPHAInnate Pharma3.1489 of 5 stars$2.00+1.0%$6.50+225.7%-6.8%$184.82M$21.77M0.00220Gap UpMCRBSeres Therapeutics2.1804 of 5 stars$21.14+2.6%$14.33-32.2%+19.2%$183.62M$126.32M-4.56330News CoverageFBRXForte Biosciences2.6703 of 5 stars$14.53+0.7%$68.00+368.0%+224.2%$180.65MN/A-0.895 Related Companies and Tools Related Companies MediWound Alternatives SELLAS Life Sciences Group Alternatives Journey Medical Alternatives Protara Therapeutics Alternatives FitLife Brands Alternatives China SXT Pharmaceuticals Alternatives Avalo Therapeutics Alternatives Innate Pharma Alternatives Seres Therapeutics Alternatives Forte Biosciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ATNM) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredBuy alert: Move $1,000 before Tesla’s Optimus launchElon's $1,000,000,000,000 payday Elon Musk just made his biggest insider purchase of Tesla stock ever. He's...Altimetry | SponsoredWhat Wall Street Won’t Say Out LoudDiscover the 7 key indicators before everyone else doesAmerican Alternative | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Actinium Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Actinium Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
